Meier U, Bartels P
Department of Neurosurgery, Unfallkrankenhaus Berlin, Germany.
Eur Neurol. 2001;46(4):178-86. doi: 10.1159/000050801.
The intrathecal infusion test is a reliable method for diagnosing normal-pressure hydrocephalus (NPH).
Between May 1982 and January 1997, we investigated 200 patients suspected of having NPH by carrying out an intrathecal infusion test with a constant-flow technique. The resistance to cerebrospinal fluid outflow in the intrathecal infusion test was the main criterion for grouping patients into those with NPH or those with cerebral atrophy. A further differentiation into early stage and advanced stage was made by measuring the compliance, this being the secondary criterion.
In 107 patients (54%), the diagnosis of NPH could be confirmed. Of these, 102 patients (95%) underwent a shunt operation. Graduation of NPH and cerebral atrophy following the results of the infusion test at an early stage and an advanced stage allows prognostic evaluations about the course of disease to be made. Patients with NPH at an early stage reported an improvement of their symptoms in the follow-up after a shunt operation in 65% of cases, while 50% of those with advanced-stage NPH reported improvement.
The computer- aided infusion test allows a reliable differentiation between patients with NPH and those with cerebral atrophy.
鞘内输注试验是诊断正常压力脑积水(NPH)的可靠方法。
1982年5月至1997年1月期间,我们采用恒流技术进行鞘内输注试验,对200例疑似NPH的患者进行了研究。鞘内输注试验中脑脊液流出阻力是将患者分为NPH患者和脑萎缩患者的主要标准。通过测量顺应性进行进一步的早期和晚期区分,这是次要标准。
107例患者(54%)确诊为NPH。其中,102例患者(95%)接受了分流手术。根据早期和晚期输注试验结果对NPH和脑萎缩进行分级,有助于对疾病进程进行预后评估。早期NPH患者在分流手术后的随访中,65%的患者症状有所改善,而晚期NPH患者中这一比例为50%。
计算机辅助输注试验能够可靠地区分NPH患者和脑萎缩患者。